Literature DB >> 26476264

The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy.

Michael Von Korff1, Sascha Dublin2, Rod L Walker3, Michael Parchman3, Susan M Shortreed4, Ryan N Hansen5, Kathleen Saunders3.   

Abstract

UNLABELLED: Avoiding high opioid doses may reduce chronic opioid therapy (COT) risks, but the feasibility of reducing opioid doses in community practice is unknown. Washington State and a health plan's group practice implemented initiatives to reduce high-dose COT prescribing. The group practice physicians were exposed to both initiatives, whereas contracted physicians were exposed only to statewide changes. Using interrupted time series analyses, we assessed whether these initiatives reduced opioid doses among COT patients in group practice (n = 16,653) and contracted care settings (n = 5,552). From 2006 to June 2014, the percentage of COT patients receiving ≥120 mg morphine equivalent dose declined from 16.8% to 6.3% in the group practice versus 20.6 to 13.6% among COT patients of contracted physicians. The proportion receiving excess opioid days supplied declined from 24.0 to 10.4% among group practice COT patients and from 20.1 to 14.7% among COT patients of contracted physicians. Reductions in prescribing of high opioid dose and excess opioid days supplied followed state and health plan initiatives to change opioid prescribing. Reductions were substantially greater in the group practice setting that implemented additional initiatives to alter shared physician expectations regarding appropriate COT prescribing, compared with the contracted physicians' patients. PERSPECTIVE: Washington State and a health plan's group practice implemented initiatives to reduce high-dose COT prescribing. Group practice physicians were exposed to both initiatives, whereas the health plan's contracted physicians were exposed to only the statewide changes. Reductions in prescribing of high opioid dose, average daily dose, and excess opioid days supplied followed state and health plan initiatives to change opioid prescribing. Reductions were substantially greater in the group practice setting that implemented additional initiatives to alter shared physician expectations regarding appropriate COT prescribing, compared with the contracted physicians' patients.
Copyright © 2016 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Opioids; chronic pain; practice change

Mesh:

Substances:

Year:  2015        PMID: 26476264      PMCID: PMC4698093          DOI: 10.1016/j.jpain.2015.10.002

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  19 in total

1.  Segmented regression analysis of interrupted time series studies in medication use research.

Authors:  A K Wagner; S B Soumerai; F Zhang; D Ross-Degnan
Journal:  J Clin Pharm Ther       Date:  2002-08       Impact factor: 2.512

2.  Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline.

Authors:  Gary M Franklin; Jaymie Mai; Judith Turner; Mark Sullivan; Thomas Wickizer; Deborah Fulton-Kehoe
Journal:  Am J Ind Med       Date:  2011-12-27       Impact factor: 2.214

Review 3.  Major increases in opioid analgesic abuse in the United States: concerns and strategies.

Authors:  Wilson M Compton; Nora D Volkow
Journal:  Drug Alcohol Depend       Date:  2005-07-14       Impact factor: 4.492

4.  Changes in opioid prescribing for Washington workers' compensation claimants after implementation of an opioid dosing guideline for chronic noncancer pain: 2004 to 2010.

Authors:  Renu K Garg; Deborah Fulton-Kehoe; Judith A Turner; Amy M Bauer; Thomas Wickizer; Mark D Sullivan; Gary M Franklin
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

5.  A reanalysis of cluster randomized trials showed interrupted time-series studies were valuable in health system evaluation.

Authors:  Atle Fretheim; Fang Zhang; Dennis Ross-Degnan; Andrew D Oxman; Helen Cheyne; Robbie Foy; Steve Goodacre; Jeph Herrin; Ngaire Kerse; R James McKinlay; Adam Wright; Stephen B Soumerai
Journal:  J Clin Epidemiol       Date:  2014-12-11       Impact factor: 6.437

6.  On the undiffusion of established practices.

Authors:  Frank Davidoff
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

7.  Ethical physician incentives--from carrots and sticks to shared purpose.

Authors:  Nikola Biller-Andorno; Thomas H Lee
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

8.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

9.  De facto long-term opioid therapy for noncancer pain.

Authors:  Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

10.  Chronic opioid therapy risk reduction initiative: impact on urine drug testing rates and results.

Authors:  Judith A Turner; Kathleen Saunders; Susan M Shortreed; Suzanne E Rapp; Stephen Thielke; Linda LeResche; Kim M Riddell; Michael Von Korff
Journal:  J Gen Intern Med       Date:  2013-10-19       Impact factor: 5.128

View more
  21 in total

1.  American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.

Authors:  Amanda M Brandow; C Patrick Carroll; Susan Creary; Ronisha Edwards-Elliott; Jeffrey Glassberg; Robert W Hurley; Abdullah Kutlar; Mohamed Seisa; Jennifer Stinson; John J Strouse; Fouza Yusuf; William Zempsky; Eddy Lang
Journal:  Blood Adv       Date:  2020-06-23

2.  Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Clinical Trial.

Authors:  Jane M Liebschutz; Ziming Xuan; Christopher W Shanahan; Marc LaRochelle; Julia Keosaian; Donna Beers; George Guara; Kristen O'Connor; Daniel P Alford; Victoria Parker; Roger D Weiss; Jeffrey H Samet; Julie Crosson; Phoebe A Cushman; Karen E Lasser
Journal:  JAMA Intern Med       Date:  2017-09-01       Impact factor: 21.873

3.  The Impact of Substance Abuse on Heart Failure Hospitalizations.

Authors:  Marin Nishimura; Harpreet Bhatia; Janet Ma; Stephen D Dickson; Laith Alshawabkeh; Eric Adler; Alan Maisel; Michael H Criqui; Barry Greenberg; Isac C Thomas
Journal:  Am J Med       Date:  2019-07-29       Impact factor: 4.965

4.  Primary Care Clinic Re-Design for Prescription Opioid Management.

Authors:  Michael L Parchman; Michael Von Korff; Laura-Mae Baldwin; Mark Stephens; Brooke Ike; DeAnn Cromp; Clarissa Hsu; Ed H Wagner
Journal:  J Am Board Fam Med       Date:  2017-01-02       Impact factor: 2.657

5.  Outcome-adaptive lasso: Variable selection for causal inference.

Authors:  Susan M Shortreed; Ashkan Ertefaie
Journal:  Biometrics       Date:  2017-03-08       Impact factor: 2.571

6.  The Future of the Patient-Centered Outcomes Research Institute (PCORI).

Authors:  Michael A Fischer; Steven M Asch
Journal:  J Gen Intern Med       Date:  2019-11       Impact factor: 5.128

7.  Team-Based Clinic Redesign of Opioid Medication Management in Primary Care: Effect on Opioid Prescribing.

Authors:  Michael L Parchman; Robert B Penfold; Brooke Ike; David Tauben; Michael Von Korff; Mark Stephens; Kari A Stephens; Laura-Mae Baldwin
Journal:  Ann Fam Med       Date:  2019-07       Impact factor: 5.166

8.  Impact of Opioid Dose Reduction and Risk Mitigation Initiatives on Chronic Opioid Therapy Patients at Higher Risk for Opioid-Related Adverse Outcomes.

Authors:  Manu Thakral; Rod L Walker; Kathleen Saunders; Susan M Shortreed; Sascha Dublin; Michael Parchman; Ryan N Hansen; Evette Ludman; Karen J Sherman; Michael Von Korff
Journal:  Pain Med       Date:  2018-12-01       Impact factor: 3.750

9.  Association Between Preoperative Opioid and Benzodiazepine Prescription Patterns and Mortality After Noncardiac Surgery.

Authors:  Martin I Sigurdsson; Solveig Helgadottir; Thorir E Long; Dadi Helgason; Nathan H Waldron; Runolfur Palsson; Olafur S Indridason; Ingibjorg J Gudmundsdottir; Tomas Gudbjartsson; Gisli H Sigurdsson
Journal:  JAMA Surg       Date:  2019-08-21       Impact factor: 14.766

10.  A Comprehensive, Multimodal, Interdisciplinary Approach to Chronic Non-Cancer Pain Management in a Family Medicine Clinic: A Retrospective Cohort Review.

Authors:  Edward Kwon; Christopher Stange; Katy Reichlin; Hamilton Vernon; Akira Miyanari; Elizabeth Bier; Hind Beydoun; Virginia Kalish
Journal:  Perm J       Date:  2021-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.